Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An Open-Label Taste Assessment of Tricaprilin Formulated as a Powder for Reconstitution in Healthy Panelists

Trial Profile

An Open-Label Taste Assessment of Tricaprilin Formulated as a Powder for Reconstitution in Healthy Panelists

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 08 Oct 2018

At a glance

  • Drugs Tricaprilin (Primary)
  • Indications Alzheimer's disease
  • Focus Adverse reactions
  • Acronyms TMS
  • Sponsors Cerecin
  • Most Recent Events

    • 04 Oct 2018 According to a Cerecin media release, Accera changed its name to Cerecin.
    • 27 Sep 2018 Status changed from recruiting to active, no longer recruiting.
    • 11 Sep 2018 Planned End Date changed from 30 Dec 2018 to 30 Mar 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top